Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-06-18
1989-01-31
Henderson, Christopher
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514359, 514381, A61K 3141, A61K 3144
Patent
active
048015946
ABSTRACT:
This invention provides azole derivatives, their pharmaceutical formulations, and their use in methods of inhibiting aromatase and treating or preventing estrogen-dependent diseases in mammals.
REFERENCES:
patent: 4094881 (1978-06-01), Berges
patent: 4098894 (1978-07-01), Buchal et al.
patent: 4227004 (1980-10-01), Wildonger
Chem. Abst., 71, 61296p (1969).
Chemical Abstracts 89:24368q (1978).
Fisher, et al., "5-Aroyltetrazoles," J. Org. Chem., 24, 1650 (1959).
Burgess, et al., "Synthesis . . . of . . . Azafulvenes," J. Org. Chem., 39(7), 940 (1974).
Adelstein, "Antiarrhythmic Agents . . . ", J. Med. Chem., 16(4), 309 (1973).
Balieu, et al., "Tetrazole Analogues . . . ", Acta Chemica Scandinavica, 27, 1233 (1973).
Chemical Abstracts 89:179927v (1978).
Balieu, et al., "Tetrazole Analogues . . . ", Acta Chemica Scandinavica, 26, 2951 (1972).
Zaugg et al., "Reactions of some ester alkaloids . . . ," J. Org. Chem., 23, 847 (1958).
Hirsch Kenneth S.
Jones Charles D.
Conrad Robert A.
Eli Lilly and Company
Henderson Christopher
Whitaker Leroy
LandOfFree
Aromatase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aromatase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aromatase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-177607